Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School
Colorcon
Medtronic
Dow

Last Updated: August 13, 2022

ROCURONIUM BROMIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for rocuronium bromide and what is the scope of patent protection?

Rocuronium bromide is the generic ingredient in two branded drugs marketed by Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Mylan Institutional, Piramal Critical, Prinston Inc, Sagent Pharms Inc, Sandoz Inc, Tamarang, Teva Pharms, West Ward Pharm Corp, and Organon Usa Inc, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for rocuronium bromide. Fourteen suppliers are listed for this compound.

Summary for ROCURONIUM BROMIDE
Recent Clinical Trials for ROCURONIUM BROMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wuhan Union Hospital, ChinaPhase 4
Ankara City Hospital BilkentN/A
Ain Shams UniversityEarly Phase 1

See all ROCURONIUM BROMIDE clinical trials

Pharmacology for ROCURONIUM BROMIDE

US Patents and Regulatory Information for ROCURONIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 078717-002 Nov 26, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sandoz Inc ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 079195-001 Dec 5, 2008 AP RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Gland Pharma Ltd ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 205656-002 Apr 4, 2018 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Eugia Pharma ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 206206-001 Apr 12, 2017 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ROCURONIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc ZEMURON rocuronium bromide INJECTABLE;INJECTION 020214-001 Mar 17, 1994 See Plans and Pricing See Plans and Pricing
Organon Usa Inc ZEMURON rocuronium bromide INJECTABLE;INJECTION 020214-003 Mar 17, 1994 See Plans and Pricing See Plans and Pricing
Organon Usa Inc ZEMURON rocuronium bromide INJECTABLE;INJECTION 020214-002 Mar 17, 1994 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKinsey
Boehringer Ingelheim
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.